P-1507

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameP-1507

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionFree radicals scavengers

TargetsFree radicals

Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsPulmonary Disease, Chronic Obstructive

ATC CodeN/A